Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$9.99 - $18.71 $172,527 - $323,121
17,270 New
17,270 $320,000
Q3 2022

Nov 14, 2022

BUY
$12.21 - $19.7 $570,451 - $920,384
46,720 Added 275.15%
63,700 $889,000
Q2 2022

Aug 15, 2022

SELL
$11.23 - $19.59 $202,263 - $352,835
-18,011 Reduced 51.47%
16,980 $234,000
Q1 2022

May 16, 2022

BUY
$13.37 - $17.79 $467,829 - $622,489
34,991 New
34,991 $569,000
Q1 2021

May 14, 2021

SELL
$19.33 - $37.75 $629,616 - $1.23 Million
-32,572 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$24.48 - $42.47 $797,362 - $1.38 Million
32,572 New
32,572 $805,000

Others Institutions Holding ICPT

About INTERCEPT PHARMACEUTICALS, INC.


  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.